ANISH DESAI: Open Payments
NPI 1760831713 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 59 payments from 12 companies in 2025. Trend: 2023 $250 · 2024 $350 · 2025 $1,171
Food & beverage: $1,060Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $296 |
| E.R. Squibb & Sons, L.L.C. | 11 | $252 |
| Janssen Pharmaceuticals, Inc | 5 | $177 |
| ABBVIE INC. | 12 | $166 |
| Otsuka America Pharmaceutical, Inc. | 8 | $137 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Corium, LLC | 2 | $23 |
| Lundbeck LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, UZEDY, ABILIFY MAINTENA, AUSTEDO XR, REXULTI, FANAPT.
Industry payments across NJ — which companies pay providers there.
